From lab to market: Managing clinical trials risk with confidence

From lab to market: Managing clinical trials with confidence
A successful trial depends on more than good science. Delays, operational challenges, regulatory change and overlooked liabilities can all affect timelines, costs and outcomes.
Join us for a practical discussion on the risks affecting clinical trials today. Drawing on perspectives from a clinical trial sponsor, an insurer and WTW experts, we'll look at what's changing across the trial process, where programmes are most vulnerable to setbacks, and what organisations can do to reduce risk and improve resilience.
We'll cover:
What's changing in clinical trials and the implications for sponsors
Why trials are delayed, disrupted or cost more than expected
Insurance and liability issues that are often overlooked
Practical steps to strengthen trial programmes and reduce exposure to risk
The session will finish with a live Q&A, giving you the opportunity to put your questions directly to the panel.
The discussion will focus on the issues sponsors are dealing with now, with practical takeaways you can apply to your own trial programme.